Literature DB >> 4038477

Incidence of hyperbilirubinemia in breast- vs. formula-fed infants.

J A Adams, D J Hey, R T Hall.   

Abstract

A retrospective study of 233 consecutively born full-term infants was performed to determine the effect of several variables on the development of hyperbilirubinemia. Thirty-five (15%) of the infants developed peak bilirubin levels greater than 12 mg/dl in the first week of life. Step-wise multiple regression analysis revealed that breast-feeding was the most predictive of a group of eight variables for the development of hyperbilirubinemia greater than 12 mg/dl. The correlation between type of feeding and hyperbilirubinemia was significant (p less than 0.02). None of the other factors evaluated was significantly associated with hyperbilirubinemia. Breast-fed infants also were found to have a significantly higher incidence of hyperbilirubinemia greater than 15 mg/dl; 12 of 101 (12%) infants compared with 2 of 117 (2%) formula-fed infants (p less than 0.002). This group of infants accounted for the increased incidence of hyperbilirubinemia greater than 12 mg/dl in breast-fed infants. There was no significant correlation between weight loss and development of hyperbilirubinemia in the breast-fed infants.

Entities:  

Mesh:

Year:  1985        PMID: 4038477     DOI: 10.1177/000992288502400201

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  3 in total

1.  Breast mild jaundice: natural history, familial incidence and late neurodevelopmental outcome of the infant.

Authors:  E Grunebaum; J Amir; P Merlob; M Mimouni; I Varsano
Journal:  Eur J Pediatr       Date:  1991-02       Impact factor: 3.183

2.  Beta glucuronidase and hyperbilirubinaemia in breast fed infants of diabetic mothers.

Authors:  L Sirota; M Ferrera; N Lerer; F Dulitzky
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

3.  Neonatal jaundice and stool production in breast- or formula-fed term infants.

Authors:  Hannah D Buiter; Sebastiaan S P Dijkstra; Rob F M Oude Elferink; Peter Bijster; Henk A Woltil; Henkjan J Verkade
Journal:  Eur J Pediatr       Date:  2007-07-10       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.